Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Payam Nahid

Executive Director, Professor of Medicine

University of California, San Francisco

United States

Research Interests

Explore related searches

Professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Collaborators (13)

Rouxjeane Venter

Researcher

Stellenbosch University

SOUTH AFRICA

View details

Sabine Hermans

Assistant Professor

NETHERLANDS

View details

Fiona Cresswell

Clinical Associate Professor

Brighton and Sussex Medical School

UNITED KINGDOM

View details

Grant Theron

Professor (full)

Stellenbosch University

SOUTH AFRICA

View details

Jon Jacobs

Staff Scientist

Pacific Northwest National Laboratory

UNITED STATES

View details

Kelly E. Dooley

Director, Division of Infectious Diseases & Professor and Addison B. Scoville Chair in Medicine

Johns Hopkins University School of Medicine

UNITED STATES

View details

Emily A Kendall

Johns Hopkins University School of Medicine

UNITED STATES

View details

Sean Wasserman

Clinical Professor of Infectious Diseases

St George’s, University of London

UNITED KINGDOM

View details

Richard Chaisson

Professor of Medicine

Johns Hopkins University

UNITED STATES

View details

Freddie Mukasa Kibengo

Consultant Physician/Senior Research Scientist

MRC/UVRI and LSHTM Uganda Research Unit

View details

Patrick Phillips

Associate Professor

University of California, San Francisco

UNITED STATES

View details

John L Johnson

Professor of Medicine

Case Western Reserve University School of Medicine

UNITED STATES

View details

Thomas Harrison

Professor

City, University of London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Payam Nahid

Research Interests

Explore related searches

Articles (20)

Ethambutol Population Pharmacokinetics and Pharmacodynamics From a Phase 3 Confirmatory Trial for the Treatment of Tuberculosis

Diagnostic Accuracy of Tuberculosis Screening Tests in a Prospective Multinational Cohort: Chest Radiography With Computer-Aided Detection, Xpert Tuberculosis Host Response, and C-Reactive Protein

Evaluating the Cepheid Xpert TB/LTBI Research-Use-Only Assay for Detection of Active and Latent Mycobacterium tuberculosis Infection

Longitudinal Plasma Proteomic Profiling Reveals Divergent Immune Responses in Durably Cured and Relapsed Pulmonary Tuberculosis

Predicted Preferences for Tuberculosis Point-of-Care Tests Among Tuberculosis-Affected Individuals in 5 High Burden Countries

Preferences for tongue swab versus sputum collection for TB testing: a multi-country survey

Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis

Projecting the Impact and Costs of Near Point-of-Care Tuberculosis Screening Assays in Community-based Active Case Finding

Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial

C-Reactive Protein-based Screening of People with

Diagnostic accuracy of swab-based molecular tests for tuberculosis using near-point-of-care platforms: a multi-country evaluation

Diagnostic accuracy of swab-based molecular tests for tuberculosis using novel near point-of-care platforms: A multi-country evaluation

Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes

Nutritional markers and proteome in patients undergoing treatment for pulmonary tuberculosis differ by geographic region (vol 16, e0250586, 2021)

Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis

Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020

Safety and Tolerability of a Short Course of Linezolid for the Treatment of Predominantly Moderate to Severe Tuberculous Meningitis in Adults With Human Immunodeficiency Virus

Study protocol for a duration-randomized clinical trial to determine the optimal length of treatment for multidrug-resistant tuberculosis with a 5-drug regimen: The DRAMATIC trial

Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials

Collaborators (13)

Rouxjeane Venter

Sabine Hermans

Fiona Cresswell

Grant Theron

Jon Jacobs

Kelly E. Dooley

Emily A Kendall

Sean Wasserman

Richard Chaisson

Freddie Mukasa Kibengo

Patrick Phillips

John L Johnson

Thomas Harrison

Make your next move.